Cogent Biosciences, Inc.
COGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $810 | $468 | $679 | $332 |
| - Cash | $98 | $53 | $140 | $220 |
| + Debt | $17 | $19 | $20 | $3 |
| Enterprise Value | $729 | $434 | $559 | $116 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$272 | -$205 | -$142 | -$74 |
| % Margin | – | – | – | – |
| Net Income | -$256 | -$192 | -$140 | -$72 |
| % Margin | – | – | – | – |
| EPS Diluted | -2.46 | -2.42 | -2.26 | -1.85 |
| % Growth | -1.7% | -7.1% | -22.2% | – |
| Operating Cash Flow | -$208 | -$154 | -$119 | -$59 |
| Capital Expenditures | -$1 | -$3 | -$7 | -$2 |
| Free Cash Flow | -$208 | -$156 | -$126 | -$60 |